Select the publication year
Select an author  
  • INHBA is enriched in HPV-negative oropharyngeal squamous cell carcinoma and promotes cancer progression.
    Abou Kors T, Hofmann L, Betzler A, Payer K, Bens M, Truong J, von Witzleben A, Thomas J, Kraus JM, Kalaajieh R, Huber D, Ezić J, Benckendorff J, Greve J, Schuler PJ, Ottensmeier CH, Kestler HA, Hoffmann TK, Theodoraki MN, Brunner C, Laban S
    Cancer Res Commun 2024 (epub ahead of print)
  • Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia.
    Bruedigam C, Porter AH, Song A, Vroeg In de Wei G, Stoll T, Straube J, Cooper L, Cheng G, Kahl VFS, Sobinoff AP, Ling VY, Jebaraj BMC, Janardhanan Y, Haldar R, Bray LJ, Bullinger L, Heidel FH, Kennedy GA, Hill MM, Pickett HA, Abdel-Wahab O, Hartel G, Lane SW
    Nat Cancer 2024 (epub ahead of print)
  • Gut microbiome in atypical depression.
    Busch A, Roy S, Helbing DL, Colic L, Opel N, Besteher B, Walter M, Bauer M, Refisch A
    J Affect Disord 2024 (epub ahead of print)
  • Systematic computational hunting for small RNAs derived from ncRNAs during dengue virus infection in endothelial HMEC-1 cells.
    Gutierrez-Diaz A, Hoffmann S, Gallego-Gómez JC, Bermudez-Santana CI
    Front Bioinform 2024, 4, 1293412
  • Conceptual foundations of acetylcarnitine supplementation in neuropsychiatric long COVID syndrome: a narrative review.
    Helbing* DL, Dommaschk* EM, Danyeli LV, Liepinsh E, Refisch A, Sen ZD, Zvejniece L, Rocktäschel T, Stabenow LK, Schiöth HB, Walter M, Dambrova M, Besteher B
    Eur Arch Psychiatry Clin Neurosci 2024 (epub ahead of print) * equal contribution
  • Denervation alters the secretome of myofibers and thereby affects muscle stem cell lineage progression and functionality.
    Henze H, Hüttner SS, Koch P, Schüler SC, Groth M, von Eyss B, von Maltzahn J
    NPJ Regen Med 2024, 9(1), 10
  • Acetylation-induced proteasomal degradation of the activated glucocorticoid receptor limits hormonal signaling.
    Iyer-Bierhoff A, Wieczorek M, Peter SM, Ward D, Bens M, Vettorazzi S, Guehrs KH, Tuckermann JP, Heinzel T
    iScience 2024, 27(2), 108943
  • Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers.
    Jessen* M, Gertzmann* D, Liss* F, Zenk F, Bähner L, Schöffler V, Schulte C, Maric HM, Ade CP, von Eyss** B, Gaubatz** S
    Oncogene 2024 (epub ahead of print) * equal contribution, ** co-corresponding authors
  • Bashing irreproducibility with shournal.
    Kirchner T, Riege K, Hoffmann S
    Sci Rep 2024, 14(1), 4872
  • CRISPR/Cas9-Mediated Modification of PTP Expression.
    Lossius C, Kresinsky A, Quiet L, Müller JP
    Methods Mol Biol 2024, 2743, 43